Compile Data Set for Download or QSAR
Report error Found 653 for UniProtKB: Q9QZN9
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50335938((3-benzyl-3-methyl-2,3-dihydrobenzofuran-6-yl)(pip...)
Affinity DataEC50:  21.7nMAssay Description:The compound of Example 3 was tested for agonist activity at the rat CB1 (rCB1) and rCB2 receptors, at eight concentrations, in duplicate: 10, 3, 1, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM227552(US9339486, CP55,940)
Affinity DataEC50:  1.13nMAssay Description:The compound of Example 3 was tested for agonist activity at the rat CB1 (rCB1) and rCB2 receptors, at eight concentrations, in duplicate: 10, 3, 1, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50006256(CHEMBL3234670)
Affinity DataEC50:  785nMAssay Description:Agonist activity at rat CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2015
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM21283(3-[(2-iodo-5-nitrophenyl)carbonyl]-1-[(1-methylpip...)
Affinity DataEC50:  216nMAssay Description:Inverse agonist activity at rat CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2015
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM21283(3-[(2-iodo-5-nitrophenyl)carbonyl]-1-[(1-methylpip...)
Affinity DataEC50:  216nMAssay Description:Inverse agonist activity at rat CB2 receptor expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2015
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50042912(CHEMBL3354553)
Affinity DataEC50:  10nMAssay Description:Agonist activity at rat CB2 receptor assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50041001(CHEMBL3354942)
Affinity DataEC50:  52nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040997(CHEMBL3354946)
Affinity DataEC50:  5.70nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040995(CHEMBL3354948)
Affinity DataEC50:  1.5nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040994(CHEMBL3354949)
Affinity DataEC50:  6.20nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040993(CHEMBL3354950)
Affinity DataEC50:  4.80nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040992(CHEMBL3354951)
Affinity DataEC50:  18nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040961(CHEMBL3354952)
Affinity DataEC50:  13nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040991(CHEMBL3354953)
Affinity DataEC50:  47nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040990(CHEMBL3354954)
Affinity DataEC50:  6.70nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040989(CHEMBL3354955)
Affinity DataEC50:  1.20nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040988(CHEMBL3354957)
Affinity DataEC50:  4.40nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040987(CHEMBL3354958)
Affinity DataEC50:  18nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040986(CHEMBL3354959)
Affinity DataEC50:  10nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040985(CHEMBL3354960)
Affinity DataEC50:  2.90nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040984(CHEMBL3354961)
Affinity DataEC50:  591nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040983(CHEMBL3354962)
Affinity DataEC50:  12nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040982(CHEMBL3354963)
Affinity DataEC50:  39nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040981(CHEMBL3354964)
Affinity DataEC50:  88nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040980(CHEMBL3354965)
Affinity DataEC50:  183nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040979(CHEMBL3354966 | US11214548, Compound 408)
Affinity DataEC50:  67nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040978(CHEMBL3354967)
Affinity DataEC50:  326nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040977(CHEMBL3354968)
Affinity DataEC50:  32nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040976(CHEMBL3354969)
Affinity DataEC50:  34nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040975(CHEMBL3354970)
Affinity DataEC50:  35nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040974(CHEMBL3354971)
Affinity DataEC50:  7.90nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040973(CHEMBL3354972)
Affinity DataEC50:  2.80E+3nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040971(CHEMBL3354974)
Affinity DataEC50:  100nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040970(CHEMBL3354975 | US11214548, Compound 269)
Affinity DataEC50: >3.00E+4nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040969(CHEMBL3354976)
Affinity DataEC50:  50nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040968(CHEMBL3352843)
Affinity DataEC50:  376nMAssay Description:Agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040960(CHEMBL3354956)
Affinity DataEC50:  69nMAssay Description:Inverse agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50040972(CHEMBL3354973)
Affinity DataEC50:  100nMAssay Description:Inverse agonist activity at rat recombinant CB2 receptor expressed in CHOK1 cells assessed as cAMP accumulation by HTRF methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/18/2016
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50211843(GW-842166 | 2-(2,4-dichlorophenylamino)-4-trifluor...)
Affinity DataEC50:  91nMAssay Description:Agonist activity at rat CB2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50277339(2,2,3,3-tetramethyl-N-(4-methyl-3-(morpholinosulfo...)
Affinity DataEC50:  11nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50304914(N-(3,4-dimethyl-5-(morpholinosulfonyl)phenyl)-2,2,...)
Affinity DataEC50:  66nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50304915(N-(3,4-dimethyl-5-(morpholinosulfonyl)phenyl)pival...)
Affinity DataEC50:  90nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50304916(N-(3,4-dimethyl-5-(morpholinosulfonyl)phenyl)-3,3,...)
Affinity DataEC50:  11nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50304917(N-(3,4-dimethyl-5-(morpholinosulfonyl)phenyl)-2,2-...)
Affinity DataEC50:  38nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50304918(N-(3,4-dimethyl-5-(morpholinosulfonyl)phenyl)-2,2-...)
Affinity DataEC50:  21nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50304919(N-(3,4-dimethyl-5-(morpholinosulfonyl)phenyl)-2,2-...)
Affinity DataEC50:  82nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50304920(2,2-dimethyl-N-(7-(morpholinosulfonyl)-2,3-dihydro...)
Affinity DataEC50:  1.70E+3nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50304921(2,2-dimethyl-N-(4-(morpholinosulfonyl)-5,6,7,8-tet...)
Affinity DataEC50:  1.40E+3nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50304922(N-(3-(N-cyclopentylsulfamoyl)-4,5-dimethylphenyl)-...)
Affinity DataEC50:  98nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Rat)
The Cleveland Clinic Foundation

US Patent
LigandPNGBDBM50304933((S)-N-(3-(3-hydroxypyrrolidin-1-ylsulfonyl)-4,5-di...)
Affinity DataEC50:  73nMAssay Description:Agonist activity at rat brain CB2 receptor by GTPgammaS binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2010
Entry Details Article
PubMed
Displayed 1 to 50 (of 653 total ) | Next | Last >>
Jump to: